![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Switching From a TDF to a TAF-Based Single Tablet Regimen:
Week 48 Data in HIV-1 Infected Virologically Suppressed Adults
|
|
|
Reported by Jules Levin
IDSA 2015 Oct 7-11 San Diego, CA
Melanie Thompson,1 Javier Morales-Ramirez,2 Cheryl McDonald,3
Anita Rachlis,4 Christian Hoffmann,5 Antonin Lazzarin,6 Gordon Crofoot,7 Andrew Plummer,8 YaPei Liu,8 Andrew Cheng,8 Scott McCallister,8
on behalf of the Gilead GS-US-292-0109 Study Team
1AIDS Research Consortium of Atlanta, GA; 2Clinical Research Puerto Rico, San Juan, Puerto Rico;
3Tarrant County Infectious Disease Associates, Fort Worth TX; 4Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada; 5ICH Study Center, Hamburg, Germany; 6Ospedale San Raffaele, Milano, Italy; 7Gordon E Crofoot MD, PA, Houston, TX; 8Gilead Sciences, Inc., Foster City, CA
![IDSA1.gif](../images/101915/101915-1/IDSA1.gif)
![IDSA2.gif](../images/101915/101915-1/IDSA2.gif)
![IDSA3.gif](../images/101915/101915-1/IDSA3.gif)
![IDSA4.gif](../images/101915/101915-1/IDSA4.gif)
![IDSA5.gif](../images/101915/101915-1/IDSA5.gif)
![IDSA6.gif](../images/101915/101915-1/IDSA6.gif)
![IDSA7.gif](../images/101915/101915-1/IDSA7.gif)
![IDSA8.gif](../images/101915/101915-1/IDSA8.gif)
![](../images/101915/101915-1/IDSA9.gif)
![IDSA10.gif](../images/101915/101915-1/IDSA10.gif)
![IDSA11.gif](../images/101915/101915-1/IDSA11.gif)
![IDSA12.gif](../images/101915/101915-1/IDSA12.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|